RD Saúde (RADL3) paga em 31 de março valores da venda de frações de ações de bonificação – Money Times
A RD Saúde (RADL3) informou nesta terça-feira (24) que os valores referentes à venda de frações de ações decorrentes de bonificação serão creditados aos acionistas em 31 de março, na proporção das frações de ações detidas por cada investidor.
As frações remanescentes foram agrupadas em cerca de 14,9 mil ações ordinárias e vendidas em leilão na B3 em 17 de março de 2026, gerando valor líquido aproximado de R$ 348,2 mil, equivalente a R$ 23,41 por ação.
Essas frações são resultado da bonificação aprovada em assembleia realizada em 22 de dezembro de 2025, quando a companhia emitiu cerca de 34,36 milhões de novas ações, na proporção de 1 papel para cada 50 ações detidas. Os papéis foram creditados aos acionistas em 26 de dezembro de 2025.
O pagamento será feito por crédito em conta para acionistas com dados atualizados junto ao banco escriturador. Investidores com cadastro desatualizado precisarão regularizar as informações para receber os valores, enquanto os demais terão os recursos repassados pela B3 por meio das corretoras responsáveis pela custódia.
A companhia acrescentou que os montantes podem estar sujeitos à incidência de imposto de renda sobre eventuais ganhos, conforme a legislação vigente.
A RD Saúde teve lucro líquido ajustado de R$ 362 milhões no quarto trimestre de 2025, queda de cerca de 5% sobre o desempenho de um ano antes, um resultado abaixo do esperado pelo mercado, segundo dados da LSEG.
Hover overTap highlighted text for details
Source Quality
Source classification (primary/secondary/tertiary), named vs anonymous, expert credentials, variety
Summary
The article is based on a company announcement and cites data from a financial data provider, but lacks direct primary sources like named executives.
Specific Findings from the Article (2)
"A RD Saúde (RADL3) informou nesta terça-feira (24)"
Indicates the information originates from a direct company announcement.
Primary source"segundo dados da LSEG."
Cites a financial data provider (LSEG) for the quarterly profit figure.
Tertiary sourcePerspective Balance
Acknowledgment of multiple viewpoints, counterarguments, and balanced presentation
Summary
The article presents a single, factual corporate announcement without exploring alternative perspectives or counterarguments.
Specific Findings from the Article (1)
"A RD Saúde (RADL3) informou nesta terça-feira (24) que os valores referentes à venda "
The entire article reports the company's announcement without presenting other viewpoints.
One sidedContextual Depth
Background information, statistics, comprehensiveness of coverage
Summary
Provides good historical context for the bonus shares, transaction details, payment logistics, and recent financial performance.
Specific Findings from the Article (3)
"Essas frações são resultado da bonificação aprovada em assembleia realizada em 22 de dezembro de 2025"
Provides background on the origin of the fractional shares.
Background"gerando valor líquido aproximado de R$ 348,2 mil, equivalente a R$ 23,41 por ação."
Provides specific financial data from the share sale.
Statistic"A RD Saúde teve lucro líquido ajustado de R$ 362 milhões no quarto trimestre de 2025"
Provides recent financial performance context.
StatisticLanguage Neutrality
Absence of loaded, sensationalist, or politically biased language
Summary
Uses completely neutral, factual language to report corporate and financial information.
Specific Findings from the Article (2)
"os valores referentes à venda de frações de ações decorrentes de bonificação serão creditados"
Factual, descriptive language without emotional or sensationalist terms.
Neutral language"queda de cerca de 5% sobre o desempenho de um ano antes, um resultado abaixo do esperado pelo mercado"
Neutral reporting of a financial performance metric.
Neutral languageTransparency
Author attribution, dates, methodology disclosure, quote attribution
Summary
Clearly attributes the core information to the company, includes a date, and attributes the profit data to LSEG.
Specific Findings from the Article (1)
"segundo dados da LSEG."
Attributes the profit figure to a source.
Quote attributionLogical Coherence
Internal consistency of claims, absence of contradictions and unsupported causation
Summary
The article presents a logically consistent sequence of events: approval of bonus shares, issuance, sale of fractions, and upcoming payment.
Logic Issues Detected
-
Contradiction (high)
Conflicting values for 'the': 14.9 vs $348.2
"Heuristic: Values conflict between P1 and P2"
-
Contradiction (high)
Conflicting values for 'the': 14.9 vs 22
"Heuristic: Values conflict between P1 and P3"
-
Contradiction (high)
Conflicting values for 'the': 14.9 vs 26
"Heuristic: Values conflict between P1 and P4"
-
Contradiction (high)
Conflicting values for 'the': $348.2 vs 22
"Heuristic: Values conflict between P2 and P3"
-
Contradiction (high)
Conflicting values for 'the': $348.2 vs 26
"Heuristic: Values conflict between P2 and P4"
-
Contradiction (high)
Conflicting values for 'the': 22 vs 26
"Heuristic: Values conflict between P3 and P4"
Core Claims & Their Sources
-
"RD Saúde will credit proceeds from the sale of fractional bonus shares to shareholders on March 31."
Source: Attributed directly to the company announcement ('A RD Saúde (RADL3) informou...'). Primary
-
"The company's adjusted net profit was R$362 million in Q4 2025, a 5% drop year-over-year, below market expectations."
Source: Attributed to data from LSEG ('segundo dados da LSEG'). Named secondary
Logic Model Inspector
Inconsistencies FoundExtracted Propositions (6)
-
P1
"The remaining fractions were grouped into about 14.9k ordinary shares and sold at auction on B3 on March 17, 2026."
Factual In contradiction -
P2
"The sale generated net proceeds of approximately R$348.2 thousand, equivalent to R$23.41 per share."
Factual In contradiction -
P3
"The bonus was approved at a shareholder meeting on December 22, 2025, issuing about 34.36 million new shares (1 for every 50 held)."
Factual In contradiction -
P4
"The shares were credited to shareholders on December 26, 2025."
Factual In contradiction -
P5
"Payment will be made via account credit for shareholders with updated registration data."
Factual -
P6
"Amounts may be subject to income tax on any gains."
Factual
Claim Relationships Graph
Detected Contradictions (6)
View Formal Logic Representation
=== Propositions === P1 [factual]: The remaining fractions were grouped into about 14.9k ordinary shares and sold at auction on B3 on March 17, 2026. P2 [factual]: The sale generated net proceeds of approximately R$348.2 thousand, equivalent to R$23.41 per share. P3 [factual]: The bonus was approved at a shareholder meeting on December 22, 2025, issuing about 34.36 million new shares (1 for every 50 held). P4 [factual]: The shares were credited to shareholders on December 26, 2025. P5 [factual]: Payment will be made via account credit for shareholders with updated registration data. P6 [factual]: Amounts may be subject to income tax on any gains. === Constraints === P1 contradicts P2 Note: Conflicting values for 'the': 14.9 vs $348.2 P1 contradicts P3 Note: Conflicting values for 'the': 14.9 vs 22 P1 contradicts P4 Note: Conflicting values for 'the': 14.9 vs 26 P2 contradicts P3 Note: Conflicting values for 'the': $348.2 vs 22 P2 contradicts P4 Note: Conflicting values for 'the': $348.2 vs 26 P3 contradicts P4 Note: Conflicting values for 'the': 22 vs 26 === Detected Contradictions === UNSAT: P1 AND P2 Proof: Heuristic: Values conflict between P1 and P2 UNSAT: P1 AND P3 Proof: Heuristic: Values conflict between P1 and P3 UNSAT: P1 AND P4 Proof: Heuristic: Values conflict between P1 and P4 UNSAT: P2 AND P3 Proof: Heuristic: Values conflict between P2 and P3 UNSAT: P2 AND P4 Proof: Heuristic: Values conflict between P2 and P4 UNSAT: P3 AND P4 Proof: Heuristic: Values conflict between P3 and P4